583 results on '"Barbet, Jacques"'
Search Results
2. New Advances in Radioimmunotherapy for the Treatment of Cancers
3. New Advances in Radioimmunotherapy for the Treatment of Cancers
4. Coupling a gamma-ray detector with asymmetrical flow field flow fractionation (AF4): Application to a drug-delivery system for alpha-therapy
5. Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia.
6. Cancers, vers une révolution thérapeutique ?
7. Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
8. Translational molecular imaging in exocrine pancreatic cancer
9. Pretargeting in the context of theranostics and companion diagnostics in nuclear oncology
10. 211At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds
11. New Advances in Radioimmunotherapy for the Treatment of Cancers
12. Pretargeting for imaging and therapy in oncological nuclear medicine
13. Medullary Thyroid Carcinoma
14. Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy
15. Medullary Thyroid Carcinoma
16. Radioimmunoconjugates for the Treatment of Cancer
17. Radioiodinated and astatinated NHC rhodium complexes: Synthesis
18. Covalent Coupling Of Monoclonal Antibodies and Protein A To Liposomes: Specific Interaction With Cells In Vitro and In Vivo
19. Applications of Near-field Microscopes to Cell Biology
20. 18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma
21. Liposome Delivery of Cyclic AMP-Dependent Protein Kinase Inhibitor into Intact Cells: Specific Blockade of Cyclic AMP-Mediated Adrenocorticotropin Release from Mouse Anterior Pituitary Tumor Cells
22. DNA Polyintercalating Drugs: DNA Binding of Diacridine Derivatives
23. Corticotropin-Releasing Factor-Induced Adrenocorticotropin Hormone Release and Synthesis is Blocked by Incorporation of the Inhibitor of Cyclic AMP-Dependent Protein Kinase into Anterior Pituitary Tumor Cells by Liposomes
24. Differential Endocytosis of T and B Lymphocyte Surface Molecules Evaluated with Antibody-Bearing Fluorescent Liposomes Containing Methotrexate
25. Calculating an estimate of tissue integrated activity in 18F-FDG PET imaging using one SUV value
26. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT
27. Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?
28. New Advances in Radioimmunotherapy for the Treatment of Cancers
29. Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety
30. dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system
31. Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)
32. Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients
33. Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
34. Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide
35. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
36. Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?
37. Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence
38. Which radionuclides will nuclear oncology need tomorrow?
39. Cancer imaging and therapy with bispecific antibody pretargeting
40. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten
41. Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody
42. Radioimmunotherapy: Is avidin-biotin pretargeting the preferred choice among pretargeting methods?
43. Medullary Thyroid Carcinoma
44. Medullary Thyroid Carcinoma
45. Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy
46. Radiolabeled Antibodies for Cancer Imaging and Therapy
47. Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer
48. The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?
49. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
50. Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.